Follow
Laurent Poirel
Laurent Poirel
University of Fribourg
Verified email at unifr.ch
Title
Cited by
Cited by
Year
Global spread of carbapenemase-producing Enterobacteriaceae
P Nordmann, T Naas, L Poirel
Emerging infectious diseases 17 (10), 1791, 2011
29812011
Metallo-β-lactamases: the quiet before the storm?
TR Walsh, MA Toleman, L Poirel, P Nordmann
Clinical microbiology reviews 18 (2), 306-325, 2005
23372005
Multiplex PCR for detection of acquired carbapenemase genes
L Poirel, TR Walsh, V Cuvillier, P Nordmann
Diagnostic microbiology and infectious disease 70 (1), 119-123, 2011
19852011
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
LS Munoz-Price, L Poirel, RA Bonomo, MJ Schwaber, GL Daikos, ...
The Lancet infectious diseases 13 (9), 785-796, 2013
18382013
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology
L Poirel, P Nordmann
Clinical Microbiology and Infection 12 (9), 826-836, 2006
14732006
Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes
L Poirel, A Jayol, P Nordmann
Clinical microbiology reviews 30 (2), 557-596, 2017
13352017
Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae
L Poirel, C Héritier, V Tolün, P Nordmann
Antimicrobial agents and chemotherapy 48 (1), 15-22, 2004
13272004
CTX-M: changing the face of ESBLs in Europe
DM Livermore, R Canton, M Gniadkowski, P Nordmann, GM Rossolini, ...
Journal of Antimicrobial Chemotherapy 59 (2), 165-174, 2007
13212007
Carbapenem resistance in Enterobacteriaceae: here is the storm!
P Nordmann, L Dortet, L Poirel
Trends in molecular medicine 18 (5), 263-272, 2012
13122012
Emerging carbapenemases in Gram-negative aerobes
P Nordmann, L Poirel
Clinical Microbiology and Infection 8 (6), 321-331, 2002
11932002
Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community
JDD Pitout, P Nordmann, KB Laupland, L Poirel
Journal of antimicrobial chemotherapy 56 (1), 52-59, 2005
11282005
Comparative Genomics of Multidrug Resistance in Acinetobacter baumannii
PE Fournier, D Vallenet, V Barbe, S Audic, H Ogata, L Poirel, H Richet, ...
PLoS genetics 2 (1), e7, 2006
10632006
OXA-48-like carbapenemases: the phantom menace
L Poirel, A Potron, P Nordmann
Journal of Antimicrobial Chemotherapy 67 (7), 1597-1606, 2012
10492012
Rapid detection of carbapenemase-producing Enterobacteriaceae
P Nordmann, L Poirel, L Dortet
Emerging infectious diseases 18 (9), 1503, 2012
9762012
Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15
TM Coque, Â Novais, A Carattoli, L Poirel, J Pitout, L Peixe, F Baquero, ...
Emerging infectious diseases 14 (2), 195, 2008
9522008
Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance
JDD Pitout, P Nordmann, L Poirel
Antimicrobial agents and chemotherapy 59 (10), 5873-5884, 2015
8982015
Characterization of VIM-2, a Carbapenem-Hydrolyzing Metallo-β-Lactamase and Its Plasmid- and Integron-Borne Gene from a Pseudomonas aeruginosa Clinical …
L Poirel, T Naas, D Nicolas, L Collet, S Bellais, JD Cavallo, P Nordmann
Antimicrobial agents and chemotherapy 44 (4), 891-897, 2000
8682000
Diversity, epidemiology, and genetics of class D β-lactamases
L Poirel, T Naas, P Nordmann
Antimicrobial agents and chemotherapy 54 (1), 24-38, 2010
8432010
The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide
P Nordmann, L Poirel
Clinical Microbiology and Infection 20 (9), 821-830, 2014
8292014
Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology
A Potron, L Poirel, P Nordmann
International journal of antimicrobial agents 45 (6), 568-585, 2015
7932015
The system can't perform the operation now. Try again later.
Articles 1–20